MBX Biosciences Rockets Skyward: Breakthrough Hypoparathyroidism Drug Unlocks Massive Pre-Market Surge!
MBX Biosciences Unveils Groundbreaking Promise for Hypoparathyroidism Patients with Novel Experimental Drug